Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Current Assets:
Cash and cash equivalents	$ 547	$ 675
Accounts receivable (net of allowance for doubtful accounts of $12 in 2025 and $14 in 2024)	1,457	1,358
Inventories (excludes inventories of $207 in 2025 and $215 in 2024 classified in Other assets)	1,362	1,321
Other current assets	1,005	994
Total Current Assets	4,371	4,348
Property, plant and equipment, net	1,197	1,168
Goodwill	4,680	4,680
Intangibles, net	1,417	1,414
Other assets	1,491	1,491
Total Assets	13,156	13,101
Current Liabilities:
Current portion of long-term debt	20	20
Trade accounts payable	1,006	1,153
Accrued and other current liabilities	1,413	1,411
Income taxes payable	176	134
Total Current Liabilities	2,615	2,718
Long-term debt	8,936	8,860
Deferred income taxes	69	74
Other noncurrent liabilities	994	977
Total Liabilities	12,614	12,629
Contingencies (Note 15)
Organon & Co. Stockholders’ Equity:
Common stock, $0.01 par value Authorized - 500,000 Issued and outstanding - 257,950 in 2025 and 257,799 in 2024	3	3
Additional paid-in capital	130	108
Retained earnings	1,026	1,010
Accumulated other comprehensive loss	(617)	(649)
Total Stockholders’ Equity	542	472
Total Liabilities and Stockholders’ Equity	$ 13,156	$ 13,101

Accrued And Other Liabilities, Current

No definition available.

Name:	ogn_AccruedAndOtherLiabilitiesCurrent
Namespace Prefix:	ogn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).